140 related articles for article (PubMed ID: 9531614)
1. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.
Nadali G; Tavecchia L; Zanolin E; Bonfante V; Viviani S; Camerini E; Musto P; Di Renzo N; Carotenuto M; Chilosi M; Krampera M; Pizzolo G
Blood; 1998 Apr; 91(8):3011-6. PubMed ID: 9531614
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.
Zanotti R; Trolese A; Ambrosetti A; Nadali G; Visco C; Ricetti MM; Benedetti F; Pizzolo G
Ann Oncol; 2002 Dec; 13(12):1908-14. PubMed ID: 12453859
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis.
Nadali G; Vinante F; Ambrosetti A; Todeschini G; Veneri D; Zanotti R; Meneghini V; Ricetti MM; Benedetti F; Vassanelli A
J Clin Oncol; 1994 Apr; 12(4):793-7. PubMed ID: 8151321
[TBL] [Abstract][Full Text] [Related]
4. Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease.
Axdorph U; Sjöberg J; Grimfors G; Landgren O; Porwit-MacDonald A; Björkholm M
Ann Oncol; 2000 Nov; 11(11):1405-11. PubMed ID: 11142480
[TBL] [Abstract][Full Text] [Related]
5. Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival.
Christiansen I; Enblad G; Kälkner KM; Gidlöf C; Glimelius B; Tötterman TH
Leuk Lymphoma; 1995 Oct; 19(3-4):243-51. PubMed ID: 8535215
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage.
Pizzolo G; Vinante F; Chilosi M; Dallenbach F; Josimovic-Alasevic O; Diamantstein T; Stein H
Br J Haematol; 1990 Jun; 75(2):282-4. PubMed ID: 2164839
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.
Gause A; Pohl C; Tschiersch A; Da Costa L; Jung W; Diehl V; Hasenclever D; Pfreundschuh M
Blood; 1991 May; 77(9):1983-8. PubMed ID: 1850308
[TBL] [Abstract][Full Text] [Related]
8. Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis.
Vener C; Guffanti A; Pomati M; Colombi M; Alietti A; La Targia ML; Bamonti-Catena F; Baldini L
Leuk Lymphoma; 2000 Apr; 37(3-4):333-9. PubMed ID: 10752984
[TBL] [Abstract][Full Text] [Related]
9. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
Visco C; Nadali G; Vassilakopoulos TP; Bonfante V; Viviani S; Gianni AM; Federico M; Luminari S; Peethambaram P; Witzig TE; Pangalis G; Cabanillas F; Medeiros LJ; Sarris AH; Pizzolo G
Eur J Haematol; 2006 Nov; 77(5):387-94. PubMed ID: 16879607
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma.
Gause A; Jung W; Schmits R; Tschiersch A; Scholz R; Pohl C; Hasenclever D; Diehl V; Pfreundschuh M
Ann Oncol; 1992 Sep; 3 Suppl 4():49-52. PubMed ID: 1333270
[TBL] [Abstract][Full Text] [Related]
11. Soluble molecules as biological markers in Hodgkin's disease.
Nadali G; Vinante F; Chilosi M; Pizzolo G
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():99-105. PubMed ID: 9570686
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.
Zinzani PL; Pileri S; Bendandi M; Buzzi M; Sabattini E; Ascani S; Gherlinzoni F; Magagnoli M; Albertini P; Tura S
J Clin Oncol; 1998 Apr; 16(4):1532-7. PubMed ID: 9552063
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma.
Nadali G; Vinante F; Stein H; Todeschini G; Tecchio C; Morosato L; Chilosi M; Menestrina F; Kinney MC; Greer JP
J Clin Oncol; 1995 Jun; 13(6):1355-60. PubMed ID: 7751879
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD30: a possible serum tumor marker for primary effusion lymphoma.
Michai M; Goto H; Hattori S; Vaeteewoottacharn K; Wongkham C; Wongkham S; Okada S
Asian Pac J Cancer Prev; 2012; 13(10):4939-41. PubMed ID: 23244086
[TBL] [Abstract][Full Text] [Related]
15. High serum level of the soluble CD30 identifies Chinese kidney transplant recipients at high risk of unfavorable outcome.
Iv R; He Q; Wang HP; Jin J; Chen Y; Chen JH
Transplant Proc; 2008 Dec; 40(10):3375-80. PubMed ID: 19100393
[TBL] [Abstract][Full Text] [Related]
16. CD30 ligand in lymphoma patients with CD30+ tumors.
Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD).
Bengtsson A; Holm L; Bäck O; Fransson J; Scheynius A
Clin Exp Immunol; 1997 Sep; 109(3):533-7. PubMed ID: 9328133
[TBL] [Abstract][Full Text] [Related]
18. Levels of soluble CD30 in cord blood and peripheral blood during childhood are not correlated with the development of atopic disease or a family history of atopy.
Holmlund U; Bengtsson A; Nilsson C; Kusoffsky E; Lilja G; Scheynius A; Sverremark-Ekström E
Clin Exp Allergy; 2003 Nov; 33(11):1531-6. PubMed ID: 14616865
[TBL] [Abstract][Full Text] [Related]
19. Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.
Levin LI; Breen EC; Birmann BM; Batista JL; Magpantay LI; Li Y; Ambinder RF; Mueller NE; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1114-1123. PubMed ID: 28341757
[No Abstract] [Full Text] [Related]
20. Plasma-soluble CD30 in childhood tuberculosis: effects of disease severity, nutritional status, and vitamin A therapy.
Hanekom WA; Hussey GD; Hughes EJ; Potgieter S; Yogev R; Check IJ
Clin Diagn Lab Immunol; 1999 Mar; 6(2):204-8. PubMed ID: 10066655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
